Medina R, Socher S H, Han J H, Friedman P A
Department of Pharmacology, Merck Sharp and Dohme Research Laboratories, West Point, PA 19486.
Thromb Res. 1989 Apr 1;54(1):41-52. doi: 10.1016/0049-3848(89)90335-6.
It is known that either endotoxin (LPS) or interleukin-1 (IL-1) increase the activity of plasminogen activator inhibitor (PAI) in the culture media of human and bovine endothelial cells. We have confirmed these results in bovine aortic endothelial cells (BAEC). To determine if this effect was mediated by increases in the level of PAI messenger RNA (mRNA) we examined the effects of these cytokines on PAI mRNA levels in BAEC, using RNA blot analyses. Treatment of BAEC with either IL-1, LPS, or human recombinant tumor necrosis factor/cachectin (TNF) dramatically increased the level of PAI mRNA. Since elevated levels of PAI will decrease fibrinolytic potential, this mechanism is in concert with the known increase in in vivo procoagulant potential induced by these agents and could contribute to thromboembolic phenomena.
已知内毒素(LPS)或白细胞介素 - 1(IL - 1)均可增加人及牛内皮细胞培养基中纤溶酶原激活物抑制剂(PAI)的活性。我们已在牛主动脉内皮细胞(BAEC)中证实了这些结果。为确定此效应是否由PAI信使核糖核酸(mRNA)水平的升高介导,我们使用RNA印迹分析研究了这些细胞因子对BAEC中PAI mRNA水平的影响。用IL - 1、LPS或人重组肿瘤坏死因子/恶病质素(TNF)处理BAEC后,PAI mRNA水平显著升高。由于PAI水平升高会降低纤溶潜力,此机制与这些因子在体内诱导的已知促凝潜力增加相一致,并可能导致血栓栓塞现象。